SUN Pharmaceutical Industries Limited Montelukast Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Montelukast Export Records India — #14 Exporter, 106 Shipments, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Montelukast

India Pharmaceutical Trade Intelligence

$168.3M510 Suppliers138 CountriesHS 30049099

ExportsIndia → UNITED STATES58.1%India → PHILIPPINES7.9%

ImportsUNITED STATES → India$7.2K MALTA → India$6.9K

#1 Buyer: AMERISOURCE HEALTH

SUN Pharmaceutical Industries Limited — Montelukast Exporter #14 | $1.9M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Montelukast Exporter Profile

Indian Pharmaceutical Exporter · #14 for Montelukast · $1.9M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #14 Indian exporter of Montelukast with $1.9M in export value and 106 verified shipments. SUN Pharmaceutical Industries Limited holds a 1.1% market share in Montelukast exports across 6 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Montelukast Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Montelukast export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Montelukast?

Country	Value	Shipments	Share
BELGIUM	$755.4K	53	45.9%
BRAZIL	$333.0K	32	20.2%
CANADA	$302.1K	12	18.4%
MOROCCO	$214.9K	9	13.1%
PERU	$22.5K	2	1.4%

Who Are the Top Buyers of Montelukast from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$676.1K	44
M/S. SUN PHARMA CANADA INC	CANADA	$200.7K	8
M/S. RANBAXY FARMACEUTICA LTDA :	BRAZIL	$186.7K	21
M/S. SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$179.0K	7
M S RANBAXY FARMACEUTICA LTDA	BRAZIL	$72.5K	2
MS SUN PHARMA CANADA INC	CANADA	$51.3K	3
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$51.2K	4
TARO PHARMACEUTICALS INC.,	CANADA	$50.0K	1
SUN PHARMACEUTICALS MOROCCO LL	MOROCCO	$33.1K	1
M/S. RANBAXYFARMACEUTICA LTDA	BRAZIL	$30.3K	1

SUN Pharmaceutical Industries Limited supplies Montelukast to 22 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by M/S. SUN PHARMA CANADA INC (CANADA) and M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Montelukast Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
MONTELUKAST SODIUM CHEWABLE TABLETS 5MG	$115.9K	5
MONTELUKAST SODIUM CHEWABLE TABLETS 4MG	$115.0K	5
TARO-MONTELUKAST TAB 10MG PACK: 100s Bot	$75.9K	2
MONTELUKAST SODIUM TAB 10MG 3X10S BRAZ PACK Box3x10s Batch DFE0886A DFE0887A EACH TAB CONTS MONTELUKAST SODIUM CHE	$50.0K	1
TARO-MONTELUKAST TAB 10MG PACK:30s STRIP	$50.0K	1
ROMILAST CHEWABLE TABS 5MG PACK:BOX3X10SBATCH:BRE01213B EACH CHEWABLE TAB CONTS. MONTELUKAST SODIUM 5MG	$50.0K	1
MONTELUKAST RANBAXY TAB 10MG ( MONTELUKAST TAB 10MG ) PACK : 4X7S BATCH : DFF3267A, DFF3268A, DFF3269A EACH TAB CONTS: M	$50.0K	1
MONTELUKAST RANBAXY TAB 10MG ( MONTELUKAST TAB 10MG ) PACK : 4X7S BATCH : DFF3980A, DFF4032A, DFF4033A EACH TABLET CONTS	$50.0K	1
TARO-MONTELUKAST TABLETS 10MG (MONTELUKAST SODIUM TABLETS 10MG) [5167 PACK X 100'S BOTTLES] (BATCH NO. DFG1248A MFG DT:	$50.0K	1
ROMILAST CHEWABLE TABS 4MG PACK:BOX3X10SBATCH:BRE01212A EACH CHEWABLE TAB CONTS. MONTELUKAST SODIUM 4MG	$34.2K	1

SUN Pharmaceutical Industries Limited exports 89 distinct Montelukast formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MONTELUKAST SODIUM CHEWABLE TABLETS 5MG with 5 shipments worth $115.9K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Montelukast Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	HETERO LABS LIMITED	$2.9M	58	8	$50.0K
12	DR REDDYS LABORATORIES LIMITED	$2.3M	45	3	$50.0K
14	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$1.9M	106	6	$17.5K
15	MICRO LABS LIMITED	$1.8M	45	7	$39.4K
13	SANDOZ PRIVATE LIMITED	$1.3M	26	1	$50.0K

SUN Pharmaceutical Industries Limited ranks #14 among 510 Indian Montelukast exporters. Average shipment value of $17.5K compared to the market average of $144.3K. The closest competitors by value are HETERO LABS LIMITED and DR REDDYS LABORATORIES LIMITED.

Which Indian Ports Ship Montelukast Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	537	8.4%
NHAVA SHEVA SEA (INNSA1)	528	8.2%
SAHAR AIR	479	7.4%
SAHAR AIR CARGO ACC (INBOM4)	466	7.2%
DELHI AIR	451	7.0%
JNPT/ NHAVA SHEVA SEA	286	4.4%
JNPT	224	3.5%
MUNDRA SEA	214	3.3%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Montelukast Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Montelukast shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 111 individual customs records matching SUN Pharmaceutical Industries Limited exporting Montelukast, covering 89 formulations to 8 countries via 22 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 138+ countries, 1,324+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Montelukast

Montelukast

SUN Pharmaceutical Industries Limited — Montelukast Exporter Profile

SUN Pharmaceutical Industries Limited — Montelukast Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Montelukast?

Who Are the Top Buyers of Montelukast from SUN Pharmaceutical Industries Limited?

What Is India's Total Montelukast Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Montelukast Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Montelukast Exporters?

What Montelukast Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Montelukast to Key Markets

Brazil — ANVISA

Canada — HC

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Montelukast Exporters?

Which Indian Ports Ship Montelukast Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Montelukast Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Montelukast Export Data from SUN Pharmaceutical Industries Limited

Montelukast Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source